Harry George Net Worth

Harry George biography

Harry A. George serves as Independent Director of the Company. Mr. George has served on our board of directors since 2002 and served as the chair of our board of directors from December 2007 until September 2013. Mr. George co-founded Solstice Capital, a venture capital firm, in 1995 and serves as its Managing General Partner. Mr. George serves as President and CFO of Radiance Therapeutics where he also serves on the board of directors. Mr. George has served as a member of the board of directors of a number of private and public companies and is currently serving on the boards of directors of Medipacs, Inc., Post.Bid.Ship, Inc., AdiCyte, Inc. and RxActuator, Inc. and Splash Pharmaceuticals, Inc. Mr. George is also a member of the boards of directors of several non-profit organizations, including Southern Arizona Leadership Council, Desert Angels and Start-up Tucson, a member of the Board of Visitors of the McGuire Center for Entrepreneurship, and an advisor to Tech Launch Arizona. Prior to 1995, Mr. George was co-founder, Director, and Vice-President of Finance for Interleaf Inc., a software products company. Prior to his time at Interleaf, Mr. George was co-founder, Director and Vice President of Finance of Kurzweil Computer Products, Inc., a computer products company, which subsequently was purchased by Xerox Imaging Systems. Mr. George received an A.B. from Bowdoin College and, in 2012, received an Honorary Doctorate of Science from the University of Arizona. Also in 2012, the Arizona BioIndustry Association conferred upon Mr. George the John McGarrity Bioscience Leader of the Year Award. Our board of directors believes Mr. George’s detailed knowledge of our company and long tenure with us, together with his more than 40 years of experience serving as founder, operating officer, or investor with successful rapid growth technology-related companies qualify him to serve on our board of directors.

How old is Harry George?

Harry George is 71, he's been the Independent Director of HTG Molecular Diagnostics Inc since 2018. There are no older and 16 younger executives at HTG Molecular Diagnostics Inc.

What's Harry George's mailing address?

Harry's mailing address filed with the SEC is C/O HTG MOLECULAR DIAGNOSTICS, INC., 3430 E. GLOBAL LOOP, TUCSON, AZ, 85706.

Insiders trading at HTG Molecular Diagnostics Inc

Over the last 9 years, insiders at HTG Molecular Diagnostics Inc have traded over $5,630,772 worth of HTG Molecular Diagnostics Inc stock and bought 1,019,150 units worth $14,128,765 . The most active insiders traders include Plc Gsk, Holdings A/S Novo und Laurence W Lytton. On average, HTG Molecular Diagnostics Inc executives and independent directors trade stock every 64 days with the average trade being worth of $28,039. The most recent stock trade was executed by Stephen Barat on 8 June 2023, trading 888 units of HTGM stock currently worth $710.

What does HTG Molecular Diagnostics Inc do?

about htg molecular diagnostics: headquartered in tucson, arizona, htg's mission is to empower precision medicine at the local level. in 2013 the company commercialized its htg edge instrument platform and a portfolio of rna assays that leverage htg's proprietary nuclease protection chemistry. htg's product offerings have since expanded to include its htg edgeseq product line, which automates sample and targeted library preparation for next-generation sequencing. additional information is available at www.htgmolecular.com.

HTG Molecular Diagnostics Inc executives and stock owners

HTG Molecular Diagnostics Inc executives and other stock owners filed with the SEC include:

• John Lubniewski,
  President, Chief Executive Officer, Director
• John L. Lubniewski,
  Pres, CEO & Director
• Shaun D. McMeans,
  Sr. VP, CFO, Sec. & Treasurer
• Shaun McMeans,
  Chief Financial Officer, Senior Vice President, Treasurer, Secretary
• Byron T. Lawson,
  Sr. VP & Chief Commercial Officer
• Timothy Johnson,
  Executive Chairman of the Board
• Byron Lawson,
  Senior Vice President and Chief Commercial Financial Officer
• Lee McCracken,
  Independent Director
• James LaFrance,
  Independent Director
• Donnie Hardison,
  Independent Director
• Michelle Griffin,
  Independent Director
• Harry George,
  Independent Director
• Ann Hanham,
  Lead Independent Director
• Laura Beggrow,
  Pres of Diagnostics
• Dr. Stephen A. Barat Ph.D.,
  Sr. VP of Therapeutics
• Dr. Marian Navratil Ph.D.,
  Sr. VP of R&D
• Dr. Patrick C. Roche,
  Sr. VP of R&D
• Dr. Debra A. Gordon,
  Sr. VP & Chief Legal Counsel
• Laura Lee Godlewski,
  Sr. VP of Fin. & Admin.
• Dr. Maureen T. Cronin Ph.D.,
  Sr. VP & Chief Scientific Officer
• Christopher P Kiritsy,
  Director
• Stephen Barat,
  Senior VP of Therapeutics
• Debra A Gordon,
  V.P. and Chief Legal Counsel
• Lewis Shuster,
  Director
• Plc Gsk,
  10% owner
• Don M Hardison,
  Director
• Holdings A/S Novo,
  10% owner
• Nv Qiagen,
  10% owner
• Patrick C. Roche,
  SVP Research & Development
• Spaght Ventures Ii Lpfsv Ii...,
  
• Donald W Grimm,
  Director
• Capital Ventures Llc Senour...,
  
• Tim B Johnson,
  Executive Chairman
• Laurence W Lytton,
  10% owner
• Thomas W. Dubensky,
  Director
• Laura Lee Godlewski,
  SVP Finance & Administration